Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects
This study has been completed.
Study NCT01250366   Information provided by Bristol-Myers Squibb

First Received on November 22, 2010.   Last Updated on July 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HCV (Genotype 1)
Interventions listed in this trial
INX-08189
Placebo matching with INX-08189
Ribavirin
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antiviral Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services